Andrea Spivack of the School of Medicine and the Stunkard Weight Management Program provides healthy-eating guidelines.
Perelman School of Medicine
John Trojanowski of the School of Medicine says a new Alzherimer’s diagnosis process “will be a useful tool to scientists working to develop treatments that slow the progress of the disease.”
John Trojanowski of the School of Medicine is featured for his work on an Alzheimer’s diagnosis tool.
Arthur Caplan of the School of Medicine analyzes ethics questions raised by television medical dramas.
Jason Karlawish of the School of Medicine says a rush to test new pharmaceuticals can have a negative impact.
Daniel Rader of the School of Medicine says a genome scan revealing cholesterol genes is “a goldmine of new discovery.”
Researchers at the University of Pennsylvania School of Medicine, the Broad Institute, Massachusetts General Hospital, and Alnylam Pharmaceuticals Inc., are some of the first to prove that a gene linked to a disease trait by genome wide association studies (GWAS) can be clinically relevant and an important determinant of disease risk.
Click here to view the full release.